Initial List Of US Essential Medicines Focuses On Acute Care
Executive Summary
US FDA excludes chronic care products from list of medicines bolstered by domestic production investment and federal procurement requirements.
You may also be interested in...
US COVID-19 Relief Package Boosts Pharma Manufacturing Programs – More To Come?
$10bn here and $6bn there on top of what’s left from earlier CARES Act gives government more options on COVID-19 medical countermeasures.
US COVID-19 Relief Law Boosts Pharmaceutical Manufacturing Programs; Is More To Come?
$10bn here and $6bn there on top of what’s left from earlier CARES Act gives government more options on COVID-19 medical countermeasures.
Biden Launches Effort To Strengthen US Pharmaceutical Supply Chain
A fresh executive order from US president Joe Biden calls for short-term and long-term study, broad consultation, and co-ordination with allies on the domestic supply chain.